Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688513'
s Days Inventory Range Over the Past 10 Years
Min: 189.31 Med: 229.83 Max: 251.1
Current: 243.1
During the past 13 years, Chengdu Easton Biopharmaceuticals Co's highest Days Inventory was 251.10. The lowest was 189.31. And the median was 229.83.
SHSE:688513's Days Inventory is ranked worse than 61.13% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs SHSE:688513: 243.10
Inventory Turnover measures how fast the company turns over its inventory within a year.
Chengdu Easton Biopharmaceuticals Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.31.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Chengdu Easton Biopharmaceuticals Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.73.
Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Chengdu Easton Biopharmaceuticals Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Chengdu Easton Biopharmaceuticals Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Chengdu Easton Biopharmaceuticals Co Days Inventory Related Terms
Chengdu Easton Biopharmaceuticals Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chengdu Easton Biopharmaceuticals Co Days Inventory Chart
SHSE:688513 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Chengdu Easton Biopharmaceuticals Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chengdu Easton Biopharmaceuticals Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Chengdu Easton Biopharmaceuticals Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Chengdu Easton Biopharmaceuticals Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chengdu Easton Biopharmaceuticals Co (SHSE:688513) has a Days Inventory of 294.60 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Chengdu Easton Biopharmaceuticals Co and its competitors. This is 28% above median its historical median of 229.83. Over the past decade, Chengdu Easton Biopharmaceuticals Co's Days Inventory has ranged from 189.31 to 251.10. According to the industry distribution chart, Chengdu Easton Biopharmaceuticals Co ranks #390 out of 638 companies in the Biotechnology industry, placing it in the top 61.1%.
Is Chengdu Easton Biopharmaceuticals Co's Days Inventory too high?
Chengdu Easton Biopharmaceuticals Co's current Days Inventory of 294.60 is 28% above median its 10-year median of 229.83. Over the past 10 years, this metric has ranged from a low of 189.31 to a high of 251.10. The Biotechnology industry median Days Inventory is 183.20. Chengdu Easton Biopharmaceuticals Co's value of 294.60 is 60.8% above this industry median. Based on the distribution chart, Chengdu Easton Biopharmaceuticals Co ranks #390 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Chengdu Easton Biopharmaceuticals Co has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chengdu Easton Biopharmaceuticals Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chengdu Easton Biopharmaceuticals Co ranks #390 out of 638 companies for Days Inventory. This places Chengdu Easton Biopharmaceuticals Co in the lower half of its industry. The industry median Days Inventory is 183.20. Chengdu Easton Biopharmaceuticals Co's value of 294.60 is 60.8% above this benchmark. Historically, Chengdu Easton Biopharmaceuticals Co's own Days Inventory has ranged from 189.31 to 251.10 over the past decade. While the company's 10-year median is 229.83 vs. the industry median of 183.20, Chengdu Easton Biopharmaceuticals Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chengdu Easton Biopharmaceuticals Co's current Days Inventory of 294.60 is 60.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Chengdu Easton Biopharmaceuticals Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chengdu Easton Biopharmaceuticals Co's current Days Inventory is 294.60, which is 28% above median its own 10-year median of 229.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chengdu Easton Biopharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Chengdu Easton Biopharmaceuticals Co (SHSE:688513) is currently considered Fairly Valued. The stock's GF Value™ is ¥48.27, compared to a current price of ¥48.93 — trading 1.4% above its estimated fair value. The current Days Inventory is 294.60, which is 28% above median its 10-year median of 229.83 and 60.8% above the Biotechnology industry median of 183.20. Chengdu Easton Biopharmaceuticals Co's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Chengdu Easton Biopharmaceuticals Co (SHSE:688513), the current Days Inventory is 294.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Overvalued in 2026?
Based on GuruFocus' analysis, Chengdu Easton Biopharmaceuticals Co stock appears to be overvalued.
The current stock price of ¥48.93 is trading 1.4% above its estimated GF Value™ of ¥48.27.
GuruFocus considers Chengdu Easton Biopharmaceuticals Co to be Fairly Valued.
Key valuation signals for SHSE:688513:
Days Inventory: 294.60 (28% above median its 10-year median of 229.83)
GF Value™: ¥48.27 vs. price of ¥48.93 (1.4% above fair value)
Industry Position: 60.8% above the Biotechnology median (#390 of 638)
No single metric tells the full story. See the SHSE:688513 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chengdu Easton Biopharmaceuticals Co Business Description
Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.
91GF Score
Get the complete analysis for SHSE:688513
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688513 has been successfully added to your 
